{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:13:10Z","timestamp":1791252790581,"version":"4.1.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1097\/mnh.0b013e32834902ad","type":"journal-article","created":{"date-parts":[[2011,6,11]],"date-time":"2011-06-11T02:53:53Z","timestamp":1307760833000},"page":"449-456","source":"Crossref","is-referenced-by-count":29,"title":["Aging and antihypertensive medication-related complications in the chronic kidney disease patient"],"prefix":"10.1097","volume":"20","author":[{"given":"Zachary A.","family":"Marcum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda F.","family":"Fried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210205","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/ki.2008.319","article-title":"The aging kidney.","volume":"74","author":"Zhou","year":"2008","journal-title":"Kidney Int"},{"key":"R2-2-20210205","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1053\/j.ackd.2010.04.003","article-title":"Hypertension and chronic kidney disease in the elderly.","volume":"17","author":"Kithas","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"key":"R3-2-20210205","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1093\/ndt\/gfp357","article-title":"Prevalence of ambulatory hypertension in elderly patients with CKD stages 3 and 4.","volume":"24","author":"Tomlinson","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R4-2-20210205","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0140-6736(85)91783-0","article-title":"Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial.","volume":"1","author":"Amery","year":"1985","journal-title":"Lancet"},{"key":"R5-2-20210205","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/bmj.293.6555.1145","article-title":"Randomised trial of treatment of hypertension in elderly patients in primary care.","volume":"293","author":"Coope","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"R6-2-20210205","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.1991.03460240051027","article-title":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension.","volume":"265","year":"1991","journal-title":"JAMA"},{"key":"R7-2-20210205","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.304.6824.405","article-title":"Medical Research Council trial of treatment of hypertension in older adults: principal results.","volume":"304","year":"1992","journal-title":"BMJ"},{"key":"R8-2-20210205","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(97)05381-6","article-title":"Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension.","volume":"350","author":"Staessen","year":"1997","journal-title":"Lancet"},{"key":"R9-2-20210205","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/S0140-6736(99)10327-1","article-title":"Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study.","volume":"354","author":"Hansson","year":"1999","journal-title":"Lancet"},{"key":"R10-2-20210205","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"R11-2-20210205","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older.","volume":"358","author":"Beckett","year":"2008","journal-title":"N Engl J Med"},{"key":"R13-2-20210205","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report.","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"R14-2-20210205","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/01.mjt.0000183719.84390.4d","article-title":"Pharmacokinetic-pharmacodynamic crisis in the elderly.","volume":"14","author":"ElDesoky","year":"2007","journal-title":"Am J Ther"},{"key":"R15-2-20210205","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0749-0690(18)30621-9","article-title":"Antihypertensive therapy in the elderly.","volume":"6","author":"Messerli","year":"1990","journal-title":"Clin Geriatr Med"},{"key":"R16-2-20210205","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1472-8206.2007.00473.x","article-title":"Clinical pharmacology in the geriatric patient.","volume":"21","author":"Hilmer","year":"2007","journal-title":"Fundam Clin Pharmacol"},{"key":"R17-2-20210205","first-page":"587","article-title":"Value of angiotensin converting enzyme inhibitors in the elderly: the example of perindopril.","volume":"11","author":"Forette","year":"1989","journal-title":"Clin Exp Hypertens A"},{"key":"R18-2-20210205","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1001\/archinternmed.2009.284","article-title":"Risk of hyperkalemia in nondiabetic patients with chronic kidney disease receiving antihypertensive therapy.","volume":"169","author":"Weinberg","year":"2009","journal-title":"Arch Intern Med"},{"key":"R19-2-20210205","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/pds.1923","article-title":"Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril.","volume":"19","author":"Johnson","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R20-2-20210205","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1503\/cmaj.101333","article-title":"The safety of combining angiotensin-converting enzyme inhibitors with angiotensin-receptor blockers in elderly patients: a population-based longitudinal analysis.","volume":"183","author":"McAlister","year":"2011","journal-title":"CMAJ"},{"key":"R21-2-20210205","first-page":"685","article-title":"Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern Arch Intern M","volume":"160","author":"Bakris","year":"2000","journal-title":"ed"},{"key":"R22-2-20210205","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(08)61236-2","article-title":"Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.","volume":"372","author":"Mann","year":"2008","journal-title":"Lancet"},{"key":"R23-2-20210205","first-page":"1086","article-title":"Blood pressure control in chronic kidney disease: is less really more J Am Soc N","volume":"21","author":"Lewis","year":"2010","journal-title":"ephrol"},{"key":"R24-2-20210205","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1212\/WNL.46.5.1470","article-title":"Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology.","volume":"46","year":"1996","journal-title":"Neurology"},{"key":"R25-2-20210205","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2165\/00002512-200522010-00004","article-title":"Postural blood pressure changes and orthostatic hypotension in the elderly patient: impact of antihypertensive medications.","volume":"22","author":"Hajjar","year":"2005","journal-title":"Drugs Aging"},{"key":"R26-2-20210205","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1159\/000237742","article-title":"Predictors of hyperkalemia risk following hypertension control with aldosterone blockade.","volume":"30","author":"Khosla","year":"2009","journal-title":"Am J Nephrol"},{"key":"R27-2-20210205","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/HYPERTENSIONAHA.108.128017","article-title":"Hyperkalemia risk in chronic kidney disease: deterrent to the use of aldosterone receptor antagonism or not.","volume":"53","author":"Sica","year":"2009","journal-title":"Hypertension"},{"key":"R30-2-20210205","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2165\/00002512-199812060-00006","article-title":"Important drug-drug interactions in the elderly.","volume":"12","author":"Seymour","year":"1998","journal-title":"Drugs Aging"},{"key":"R31-2-20210205","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1503\/cmaj.100702","article-title":"The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers.","volume":"183","author":"Wright","year":"2011","journal-title":"CMAJ"},{"key":"R32-2-20210205","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa040135","article-title":"Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study.","volume":"351","author":"Juurlink","year":"2004","journal-title":"N Engl J Med"},{"key":"R33-2-20210205","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJM199911043411907","article-title":"Calcium-antagonist drugs.","volume":"341","author":"Abernethy","year":"1999","journal-title":"N Engl J Med"},{"key":"R34-2-20210205","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/HYPERTENSIONAHA.107.088088","article-title":"Association of antihypertensive therapy and diastolic hypotension in chronic kidney disease.","volume":"50","author":"Peralta","year":"2007","journal-title":"Hypertension"},{"key":"R35-2-20210205","first-page":"397","article-title":"Is there a role for direct renin inhibitors in chronic kidney disease Curr Opin Nephrol H","volume":"18","author":"Peixoto","year":"2009","journal-title":"ypertens"},{"key":"R36-2-20210205","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1001\/archinternmed.2008.511","article-title":"Comparative effectiveness of beta-blockers in elderly patients with heart failure.","volume":"168","author":"Kramer","year":"2008","journal-title":"Arch Intern Med"},{"key":"R37-2-20210205","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1161\/01.CIR.92.5.1326","article-title":"Nifedipine. Dose-related increase in mortality in patients with coronary heart disease.","volume":"92","author":"Furberg","year":"1995","journal-title":"Circulation"},{"key":"R38-2-20210205","first-page":"489","article-title":"Development and pilot testing of guidelines to monitor high-risk medications in the ambulatory setting.","volume":"16","author":"Tjia","year":"2010","journal-title":"Am J Manag Care"}],"container-title":["Current Opinion in Nephrology & Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MNH.0b013e32834902ad","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:31:35Z","timestamp":1786044695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00041552-201109000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mnh.0b013e32834902ad","relation":{},"ISSN":["1062-4821"],"issn-type":[{"value":"1062-4821","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}